Stock Evaluator: NewGenIvf Group Limited (NIVF)
NewGenIvf Group Limited NIVF
$0.72
0.00
0.60%
September 18, 2026 4:00:00 PM
EST
Volume: 57,201
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also offers IVF treatment; surrogacy and ancillary caring services, and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company provides its services through clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.
Financial Summary
| Share Statistics | NIVF | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1.7 | $1,732.1 | 1% |
|
| Shares Out (Mil) | 0.0 | 76.7 | 0% |
|
| Institutional Ownership | 2.3% | 86.8% | 3% |
|
| Float (Mil) | 1.2 | 53.9 | 3% |
|
| Beta | -0.04 | 0.82 | 5% |
|
| Avg Daily Volume (000s) | 105 | 597 | 35% |
|
| Price Change (52-week) |
(99.9%) | 79.8% | 0% |
|
| Growth | NIVF | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 10.4% | na |
|
| Net Income (5yr) | na | (0.2%) | na |
|
| EPS (5yr) | na | 3.0% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (17.9%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | NIVF | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $5 | $1,504 | 6% |
|
| Net Income (TTM) (Mil) | $10 | $28 | 45% |
|
| EPS (TTM) | na | $0.200 | na |
|
| Operating Cash Flow (TTM) (Mil) | ($11) | $151 | 19% |
|
| Net Cash Flow (TTM) (Mil) | $0 | $5 | 44% |
|
| Long-Term Debt (Q1) (Mil) | $4 | $373 | 24% |
|
| Enterprise Value (Q1) (Mil) | $6 | $2,343 | 6% |
|
| Valuation | NIVF | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 3.01 | na |
|
| P/E | na | 25.0 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | NIVF | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 20.2% | 27.8% | 21% |
|
| Net Margin | 209.0% | 1.3% | 100% |
|
| ROA | 54.4% | 2.2% | 99% |
|
| ROE | 77.2% | 6.8% | 95% |
|
| Liabilities to Assets | 20.6% | 61.5% | 14% |
|
| F-Score | 3 | 5 | na |
|
NewGenIvf Group Limited did not pass any screens on 9/18/2026.
